Clinical Trials Sponsored by Vernalis (R&D) Ltd

Total 72 results

Vernalis (R&D) Ltd

Completed

Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

ADHD

United States
Vernalis (R&D) Ltd

Completed

Safety and Efficacy Study in Acute Ischaemic Stroke (VASST)

Stroke

United States, Canada
Vernalis (R&D) Ltd

Completed

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

Parkinson's Disease
Vernalis (R&D) Ltd

Completed

Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States, United Kingdom, Canada, Czech Republic
Vernalis (R&D) Ltd

Completed

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

First in Man Study

United Kingdom
Vernalis (R&D) Ltd

Completed

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Parkinson's Disease

United Kingdom
Vernalis (R&D) Ltd

Completed

Safety and Efficacy of Low Doses of V24343 in Obese Subjects

Obesity

United Kingdom
Endo Pharmaceuticals
Vernalis (R&D) Ltd

Completed

A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

Menstrually Associated Migraine

United States
Endo Pharmaceuticals
Vernalis (R&D) Ltd

Completed

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches (MAM)

Migraine

Poland, United Kingdom, South Africa, Hungary, Germany
Vernalis (R&D) Ltd
Cita NeuroPharmaceuticals

Completed

A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain

Pain | Diabetic Neuropathies

United States, Canada
Brigham and Women's Hospital
Vernalis (R&D) Ltd

Completed

A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

Neuropathic Pain Due to Spinal Cord Injury

United States
Vernalis (R&D) Ltd
Syneos Health; Cita NeuroPharmaceuticals

Completed

PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets

Parkinson's Disease

Italy
Vernalis (R&D) Ltd
Manchester University NHS Foundation Trust

Terminated

Phase II Open-Label Pilot Study of V3381 in Chronic Cough

Cough

United Kingdom
Glenmark Pharmaceuticals Europe Ltd. (R&D)

Unknown

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Asthma

India
Glenmark Pharmaceuticals Europe Ltd. (R&D)

Unknown

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

India
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Not yet recruiting

The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Recruiting

SY-005 （Recombinant Human Annexin A5）in Patients With Sepsis

Sepsis

China
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Completed

The Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of HEC88473 in Healthy Subjects

Non-alcoholic Steatohepatitis

Australia
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

A Food-drug Interaction Study of SY-004 in Healthy Subjects

Type 2 Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 （Recombinant Human Annexin A5）in Healthy Subjects

Sepsis

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single-dose Incremental Intravenous Injection of SY-007 in Healthy Subjects

Cerebral Apoplexy

China
Unilever R&D
Lambda Therapeutic Research Ltd.

Completed

Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response

Blood Glucose

India
Unilever R&D
Lambda Therapeutic Research Ltd.

Completed

Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose

Blood Glucose

India
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Completed

A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects

Obesity | Healthy Subjects | T2DM (Type 2 Diabetes Mellitus)

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Suspended

SY007 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

A Drug Interaction Study of SY-004 Capsules in Healthy Subjects

Type 2 Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single Ascending Oral Doses of SY-009 in Healthy Subjects

Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Single Ascending Oral Doses of SY-008 in Healthy Subjects

Diabetes

China
Dongguan HEC Biopharmaceutical R&D Co., Ltd.

Recruiting

Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Suzhou Yabao Pharmaceutical R&D Co., Ltd.

Completed

Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China
Neurovalens Ltd.
R D Gardi Medical College, Ujjain

Completed

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety: A Randomized Clinical Trial

Anxiety

India
Neurovalens Ltd.
R D Gardi Medical College, Ujjain

Completed

Electrical Vestibular Nerve Stimulation (VeNS): A Follow-up Assessment of Long-term Usage

Safety Issues

United Kingdom
Efficacy Care R&D Ltd
Hadassah Medical Organization

Unknown

Estimation of Delirium Data Completeness

Delirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-Induced

Israel
Mepha Ltd.
SocraTec R&D GmbH; SocraMetrics GmbH

Completed

Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed Administration

Healthy

Germany
Neurovalens Ltd.
R D Gardi Medical College, Ujjain

Completed

Electrical Vestibular Nerve Stimulation (VeNS) in the Management of Parkinson's Disease

Parkinson Disease

India
CureTech Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma

Primary Hepatocellular Carcinoma

Israel
CureTech Ltd
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Chronic Hepatitis C Genotype I Infection

Chronic Hepatitis C

Israel
Allergisa Pesquisa Dermato-Cosmetica LTDA
Galderma R&D

Unknown

Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face (13244/2009)

Seborrheic Dermatitis
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Luye Pharma Group Ltd.
SocraTec R&D GmbH; SocraMetrics GmbH

Completed

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)

Healthy

Germany
SocraTec R&D GmbH
SocraMetrics GmbH; Teikoku Seiyaku Co., Ltd.

Completed

S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet

Comparative Bioavailability

Germany
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

A Study of HS-20089 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

Postmenopausal Osteoporosis

China
The National Institutes of Pharmaceutical R&D Co...

Completed

A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects

Idiopathic Pulmonary Fibrosis

United States
SocraTec R&D GmbH
Luye Pharma Group Ltd.; SocraMetrics GmbH

Completed

Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease

Patch Adhesion | Local Tolerability

Germany
Teva Pharmaceutical Industries, Ltd.

Completed

Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Belgium, France, Germany, Israel, Italy, United Kingdom
Teva Pharmaceutical Industries, Ltd.

Terminated

A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children

Growth Hormone-Deficiency

Belarus, Bulgaria, Georgia, Greece, Hungary, Israel, Poland, Romania, Russian Federation, Serbia, Spain, Turkey, Ukraine
Teva Pharmaceutical Industries, Ltd.

Completed

TL011 in Severe, Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Czechia, Hungary, Italy, Spain, United Kingdom

Clinical Trials Sponsored by Vernalis (R&D) Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations